Volume 57, Issue 6, Pages (June 2000)

Slides:



Advertisements
Similar presentations
Navdeep Tangri, Paul V.J. Komenda, Claudio Rigatto 
Advertisements

Bcl-2 overexpression prevents apoptosis-induced Madin-Darby canine kidney simple epithelial cyst formation1  Hsi-Hui Lin, Tzi-Peng Yang, Si-Tse Jiang,
Volume 82, Issue 9, Pages (November 2012)
Volume 59, Issue 5, Pages (May 2001)
Plasma sodium and hypertension
Neal X. Chen, Kalisha D. O'Neill, Toshimitsu Niwa, Sharon M. Moe 
Dylan Burger, Adeera Levin  Kidney International 
Volume 62, Issue 2, Pages (August 2002)
Anne K. Berfield, Dennis L. Andress, Christine K. Abrass 
Volume 69, Issue 4, Pages (February 2006)
Volume 64, Issue 2, Pages (August 2003)
Quiz page American Journal of Kidney Diseases
Anne K. Berfield, Dennis L. Andress, Christine K. Abrass 
Bcl-2 overexpression prevents apoptosis-induced Madin-Darby canine kidney simple epithelial cyst formation1  Hsi-Hui Lin, Tzi-Peng Yang, Si-Tse Jiang,
Neal X. Chen, Kalisha D. O'Neill, Danxia Duan, Sharon M. Moe 
Volume 54, Issue 3, Pages (September 1998)
Endothelial cell dysfunction and nitric oxide synthase
Mark F. Fillinger, MD, Susan E. O'Connor, MD, Robert J
Volume 83, Issue 6, Pages (June 2013)
Volume 69, Issue 1, Pages (January 2006)
Volume 85, Issue 3, Pages (March 2014)
Quiz Page July 2007 American Journal of Kidney Diseases
Volume 83, Issue 6, Pages (June 2013)
Volume 59, Issue 5, Pages (May 2001)
Hsueh Yang, Gabrielle Curinga, Cecilia M. Giachelli 
Volume 72, Issue 6, Pages (September 2007)
Volume 56, Issue 4, Pages (October 1999)
Bcl-2 overexpression prevents apoptosis-induced Madin-Darby canine kidney simple epithelial cyst formation1  Hsi-Hui Lin, Tzi-Peng Yang, Si-Tse Jiang,
Volume 62, Issue 1, Pages (July 2002)
Volume 82, Issue 9, Pages (November 2012)
Bisphosphonate safety and efficacy in chronic kidney disease
Jin H. Li, Xiao R. Huang, Hong-Jian Zhu, Richard Johnson, Hui Y. Lan 
Volume 58, Issue 4, Pages (October 2000)
Volume 59, Issue 6, Pages (June 2001)
The pathological role of Bax in cisplatin nephrotoxicity
Volume 65, Issue 5, Pages (May 2004)
Navdeep Tangri, Paul V.J. Komenda, Claudio Rigatto 
Volume 72, Issue 2, Pages (July 2007)
Volume 65, Issue 3, Pages (March 2004)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 57, Issue 4, Pages (April 2000)
Volume 70, Issue 6, Pages (September 2006)
Urinary biomarkers: the future looks promising
M.-J. Wu, M.-C. Wen, Y.-T. Chiu, Y.-Y. Chiou, K.-H. Shu, M.-J. Tang 
Volume 60, Issue 1, Pages (July 2001)
Nephrology Crossword: Glomerulonephritis
Role of mesangial cells and gap junctions in tubuloglomerular feedback
Volume 68, Issue 4, Pages (October 2005)
Inhibition of Type I Procollagen Production in Photodamage: Correlation Between Presence of High Molecular Weight Collagen Fragments and Reduced Procollagen.
Volume 55, Issue 6, Pages (June 1999)
New drug toxicities in the onco-nephrology world
Susan K. Fellner, William J. Arendshorst  Kidney International 
Lu-Cheng Cao, Thomas Honeyman, Julie Jonassen, Cheryl Scheid 
Red cell traverse through thin glomerular basement membrane
Nanocrystals seed calcification in more ways than one
The vascular secret of Klotho
Volume 55, Pages S3-S16 (June 1999)
Increased importin α protein expression in diabetic nephropathy
Quiz page answers August 2003
Volume 83, Issue 4, Pages (April 2013)
Volume 70, Issue 3, Pages (August 2006)
Volume 71, Issue 9, Pages (May 2007)
Effects of hyperglycemia on the differential expression of insulin and insulin-like growth factor-I receptors in human normal peritoneal and adhesion.
Volume 77, Issue 5, Pages (March 2010)
Cell biological and physicochemical aspects of arterial calcification
Volume 57, Issue 6, Pages (June 2000)
TGF-β1 down-regulates induced expression of both class II MHC and B7-1 on primary murine renal tubular epithelial cells  Nazifa Banu, Catherine M. Meyers 
Quiz page December 2003 American Journal of Kidney Diseases
Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in.
Presentation transcript:

Volume 57, Issue 6, Pages 2492-2501 (June 2000) Effect of insulin and heparin on glucose-induced vascular damage in cell culture  Anil K. Mandal, Jonathan T. Puchalski, Susan Lemley-Gillespie, Catherine A. Taylor, Masakazu Kohno  Kidney International  Volume 57, Issue 6, Pages 2492-2501 (June 2000) DOI: 10.1046/j.1523-1755.2000.00108.x Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 1 Light microscopy of endothelial cells exposed to physiologic and pathologic concentrations of glucose. (A) Endothelial cells (ECs) that grew in the presence of physiologic (5 mmol/L, 90 mg/dL) concentrations of D-glucose demonstrate confluency (×400). (B) Those cells that are exposed to pathologic glucose conditions (30 mmol/L, 540 mg/dL) show pronounced intercellular gaps (×400). Kidney International 2000 57, 2492-2501DOI: (10.1046/j.1523-1755.2000.00108.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 2 Scanning electron microscopy demonstrating the ability of heparin and insulin to restore EC confluency. (A; × 1250) Demonstrates the intercellular gaps that form when ECs are exposed to pathologic concentrations of glucose (30 mmol/L, 540 mg/dL). (B; ×1250) Illustrates that cells treated with insulin (20 U/100 mL) in the presence of high-glucose concentrations are able to maintain their intercellular adhesions and confluency. (C; ×1250) Shows that cells treated with heparin (500 U/mL) demonstrate confluency similar to those of insulin-treated cells, despite the presence of pathologic glucose concentrations. Kidney International 2000 57, 2492-2501DOI: (10.1046/j.1523-1755.2000.00108.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 3 Transmission electron microscopy study of ECs. (A) ECs treated with FCS (control) show complete adhesion between cells with intact intercellular membrane (×6500). (B) ECs treated with physiological concentration of glucose (5 mmol/L or 90 mg/dL) show no difference from control study (×6500). (C) ECs treated with pathological concentration of glucose (30 mmol/L or 540 mg/dL) show wide separation of the cells (as in Figures 1b and 2a) with complete loss of intercellular microvilli. Intercellular microvilli have disappeared or fragmented (×6500). (D) ECs treated with pathological concentration of glucose and insulin (20U/100 mL) show adequate intercellular microvilli and adhesion (×6500). Kidney International 2000 57, 2492-2501DOI: (10.1046/j.1523-1755.2000.00108.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 4 Immunofluorescence microscopy showing the effect of insulin and/or heparin on vimentin expression induced by different glucose concentration. (A; control) ECs treated with FCS show slight vimentin expression (×400). (B) ECs treated with 30 mmol/L mannitol show vimentin expression similar to control (×400). (C) ECs treated with heparin (10 U/mL) alone show attenuation of vimentin expression compared with control (×400). (D) ECs treated with physiological concentration of glucose (90 mg/dL) show 2+ vimentin expression and slight reorganization appearing as vesicles (×400). (E) ECs treated with a high concentration of glucose (540 mg/dL) show a 4+ increase in vimentin expression. No reorganization or vesicle is evident (×400). (F) ECs treated with high concentration of glucose and heparin show good reorganization giving rise to vesicle-like appearances (×400). (G) ECs treated with a high concentration of glucose (540 mg/dL) and insulin and heparin show marked reorganization of vimentin expression giving rise to pronounced vesiculation appearances (×400). Kidney International 2000 57, 2492-2501DOI: (10.1046/j.1523-1755.2000.00108.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 4 Immunofluorescence microscopy showing the effect of insulin and/or heparin on vimentin expression induced by different glucose concentration. (A; control) ECs treated with FCS show slight vimentin expression (×400). (B) ECs treated with 30 mmol/L mannitol show vimentin expression similar to control (×400). (C) ECs treated with heparin (10 U/mL) alone show attenuation of vimentin expression compared with control (×400). (D) ECs treated with physiological concentration of glucose (90 mg/dL) show 2+ vimentin expression and slight reorganization appearing as vesicles (×400). (E) ECs treated with a high concentration of glucose (540 mg/dL) show a 4+ increase in vimentin expression. No reorganization or vesicle is evident (×400). (F) ECs treated with high concentration of glucose and heparin show good reorganization giving rise to vesicle-like appearances (×400). (G) ECs treated with a high concentration of glucose (540 mg/dL) and insulin and heparin show marked reorganization of vimentin expression giving rise to pronounced vesiculation appearances (×400). Kidney International 2000 57, 2492-2501DOI: (10.1046/j.1523-1755.2000.00108.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 5 Immunoflourescence studies of actin concentration in vascular smooth muscle cells (VSMCs). (A) A high-glucose concentration (30 mmol/L) promotes increased expression of actin (4+) in cultured smooth muscle cells (×400). (B) Insulin is able to reduce the actin expression in smooth muscle cells toward normal levels (1+; ×400). Kidney International 2000 57, 2492-2501DOI: (10.1046/j.1523-1755.2000.00108.x) Copyright © 2000 International Society of Nephrology Terms and Conditions